Energy News / Shareholders Foundation, Inc.

NASDAQ: CORV Investor Alert: Lawsuit Alleges Securities Laws Violations by Correvio Pharma Corp.

Via: ReleaseWire

Updated 10:36 AM CST, Fri, January 31,2020

A lawsuit was filed on behalf of investors in Correvio Pharma Corp. (NASDAQ: CORV) shares over alleged securities laws violations.

San Diego, CA -- (SBWIRE) -- 01/31/2020 -- An investor, who purchased shares of Correvio Pharma Corp. (NASDAQ: CORV), filed a lawsuit over alleged violations of Federal Securities Laws by Correvio Pharma Corp.

Investors who purchased shares of Correvio Pharma Corp. (NASDAQ: CORV) have certain options and for certain investors are short and strict deadlines running. Deadline: February 10, 2020. NASDAQ: CORV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Vancouver, Canada based Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide. On December 6, 2019, U.S. Food and Drug Administration ("FDA") staffers who reviewed the Company's resubmitted New Drug Application ("NDA") for Brinavess found that the drug's benefits did not offset its risks because Brinavess was associated with "serious liabilities" including irregular heartbeat, low blood pressure, and death.

Then, on December 10, 2019, the FDA's Cardiovascular and Renal Drugs Advisory Committee ("RDAC") voted 11-2 against the resubmitted NDA, noting that the benefit-risk profile for Brinavess was inadequate to support approval.

The plaintiff claims that between October 23, 2018 and December 5, 2019, the defendants made false and/or misleading statements and/or failed to disclose that the data supporting the Resubmitted NDA for Brinavess did not minimize the significant health and safety issues observed in connection with the drug's original NDA, that the foregoing substantially diminished the likelihood that the FDA would approve the Resubmitted NDA, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Correvio Pharma Corp. (NASDAQ: CORV) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaq-corv-investor-alert-lawsuit-alleges-securities-laws-violations-by-correvio-pharma-corp-1273820.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com